摘要: Management of cancer has been unsatisfactory in the past but an understanding molecular, genetic and genomic aspects is accelerating progress therapy (Jain 2014). Several comprehensive studies have demonstrated utility gene expression profiles for classification tumors into clinically relevant subtypes prediction clinical outcomes. Role oncoproteomics personalized management was first emphasized 2004 2004). Considerable made this field during few years. Other factors that drive development are listed Table 10.1. The preceding chapter described how cell vaccines can be personalized. Information presented section will show personalization other therapies.
springer.com
sci-hub.se 参考文章(259)
Maria J. Worsham, Haythem Ali, Jadranka Dragovic, Vanessa P. Schweitzer, Molecular Characterization of Head and Neck Cancer Molecular Diagnosis & Therapy. ,vol. 16, pp. 209- 222 ,(2012) , 10.1007/BF03262210
Alexander Röth, Calvin B. Harley, Gabriela M. Baerlocher, Imetelstat (GRN163L) - Telomerase-Based Cancer Therapy Recent results in cancer research. ,vol. 184, pp. 221- 234 ,(2010) , 10.1007/978-3-642-01222-8_16
Christine L.H. Snozek, Dennis J. O'Kane, Alicia Algeciras-Schimnich, Pharmacogenetics of Solid Tumors: Directed Therapy in Breast, Lung, and Colorectal Cancer The Journal of Molecular Diagnostics. ,vol. 11, pp. 381- 389 ,(2009) , 10.2353/JMOLDX.2009.090003
Anniina Koski, Helena Ahtinen, Heidi Liljenback, Anne Roivainen, Anu Koskela, Minna Oksanen, Kaarina Partanen, Leena Laasonen, Kalevi Kairemo, Timo Joensuu, Akseli Hemminki, [(18)F]-fluorodeoxyglucose positron emission tomography and computed tomography in response evaluation of oncolytic adenovirus treatments of patients with advanced cancer. Human Gene Therapy. ,vol. 24, pp. 1029- 1041 ,(2013) , 10.1089/HUM.2013.123
Jan A. Boucek, J. Harvey Turner, Personalized Dosimetry of 131I-Rituximab Radioimmunotherapy of Non-Hodgkin Lymphoma Defined by Pharmacokinetics in Bone Marrow and Blood Cancer Biotherapy and Radiopharmaceuticals. ,vol. 29, pp. 18- 25 ,(2014) , 10.1089/CBR.2013.1490
Cancer Genome Atlas Research Network, None, Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia The New England Journal of Medicine. ,vol. 368, pp. 2059- 2074 ,(2013) , 10.1056/NEJMOA1301689
Laurent Perreard, Cheng Fan, John F Quackenbush, Michael Mullins, Nicholas P Gauthier, Edward Nelson, Mary Mone, Heidi Hansen, Saundra S Buys, Karen Rasmussen, Alejandra Ruiz Orrico, Donna Dreher, Rhonda Walters, Joel Parker, Zhiyuan Hu, Xiaping He, Juan P Palazzo, Olufunmilayo I Olopade, Aniko Szabo, Charles M Perou, Philip S Bernard, Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay Breast Cancer Research. ,vol. 8, pp. 1- 11 ,(2006) , 10.1186/BCR1399
Zhen Su, Jens Dannull, Benjamin K. Yang, Philipp Dahm, Doris Coleman, Donna Yancey, Sylvia Sichi, Donna Niedzwiecki, David Boczkowski, Eli Gilboa, Johannes Vieweg, Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer. Journal of Immunology. ,vol. 174, pp. 3798- 3807 ,(2005) , 10.4049/JIMMUNOL.174.6.3798
Kewal K. Jain, Textbook of hyperbaric medicine ,(1990)
James Suen, Vaneerat Ratanatharathorn, Ehab Hanna, Randy Breau, Dennis C. Shrieve, Xueqing Xia, Shulin Li, A Novel Alternative Approach for Prediction of Radiation Response of Squamous Cell Carcinoma of Head and Neck Cancer Research. ,vol. 61, pp. 2376- 2380 ,(2001)